Diabetes, Vol 48, Issue 10 2096-2098, Copyright © 1999 by American Diabetes Association

ARTICLES

Tumor necrosis factor-alpha-238 and -308 polymorphisms do not associated with traits related to obesity and insulin resistance

J Walston, M Seibert, CJ Yen, LJ Cheskin and RE Andersen
Division of Geriatric Medicine and Gerontology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA. jwalston@welchlink.welch.jhu.edu

Tumor necrosis factor-alpha (TNF-alpha) is expressed primarily in adipocytes, and elevated levels of this cytokine have been linked to obesity and insulin resistance. The purpose of this investigation was to test whether the TNF-alpha-308 polymorphism (previously linked to insulin resistance and increased leptin levels) and the TNF-alpha-238 polymorphism (linked to decreased insulin resistance) were associated with insulin resistance or obesity-related traits in 424 subjects self-referred to the Johns Hopkins Weight Management Center (JHWMC). There were no differences in allele frequencies of either polymorphism by obesity category in the JHWMC and a lean control group. Despite previous smaller studies that have linked insulin resistance and the 308 allele, we found no such relationship in the JHWMC population. Instead, homozygotes for this allele had a significantly lower BMI than their counterparts without the polymorphism. In addition, we found no relationship between the 238 polymorphism and BMI, fasting glucose, or log of fasting insulin.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. L. Gonzalez-Sanchez, M. J. Martinez-Calatrava, M. T. Martinez-Larrad, C. Zabena, C. Fernandez-Perez, M. Laakso, and M. Serrano-Rios Interaction of the -308G/A Promoter Polymorphism of the Tumor Necrosis Factor-{alpha} Gene with Single-Nucleotide Polymorphism 45 of the Adiponectin Gene: Effect on Serum Adiponectin Concentrations in a Spanish Population Clin. Chem., January 1, 2006; 52(1): 97 - 103. [Abstract] [Full Text] [PDF]

				Y. Wang, M. C. Y. Ng, W.-Y. So, R. Ma, G. T. C. Ko, P. C. Y. Tong, and J. C. N. Chan Association between tumour necrosis factor-{alpha} G-308A polymorphism and risk of nephropathy in obese Chinese type 2 diabetic patients Nephrol. Dial. Transplant., December 1, 2005; 20(12): 2733 - 2738. [Abstract] [Full Text] [PDF]

				J. M. Fernandez-Real and W. Ricart Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome Endocr. Rev., June 1, 2003; 24(3): 278 - 301. [Abstract] [Full Text] [PDF]

				H. Li, L. Groop, A. Nilsson, J. Weng, and T. Tuomi A Combination of Human Leukocyte Antigen DQB1*02 and the Tumor Necrosis Factor {alpha} Promoter G308A Polymorphism Predisposes to an Insulin-Deficient Phenotype in Patients with Type 2 Diabetes J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2767 - 2774. [Abstract] [Full Text] [PDF]

				D. Jaquet, D. A. Tregouet, T. Godefroy, V. Nicaud, D. Chevenne, L. Tiret, P. Czernichow, and C. Levy-Marchal Combined Effects of Genetic and Environmental Factors on Insulin Resistance Associated With Reduced Fetal Growth Diabetes, December 1, 2002; 51(12): 3473 - 3478. [Abstract] [Full Text] [PDF]

				H. F. Escobar-Morreale, R. M. Calvo, J. Sancho, and J. L. San Millan TNF-{alpha} and Hyperandrogenism: A Clinical, Biochemical, and Molecular Genetic Study J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3761 - 3767. [Abstract] [Full Text] [PDF]

				R. Rosmond, M. Chagnon, C. Bouchard, and P. Björntorp G-308A Polymorphism of the Tumor Necrosis Factor {{alpha}} Gene Promoter and Salivary Cortisol Secretion J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2178 - 2180. [Abstract] [Full Text]

				S. K. Rasmussen, S. A. Urhammer, J. N. Jensen, T. Hansen, K. Borch-Johnsen, and O. Pedersen The -238 and -308 G->A Polymorphisms of the Tumor Necrosis Factor {alpha} Gene Promotor Are Not Associated with Features of the Insulin Resistance Syndrome or Altered Birth Weight in Danish Caucasians J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1731 - 1734. [Abstract] [Full Text]